Predictors of relapse following transition to ofatumumab in relapsing-remitting multiple sclerosis. (PubMed, Mult Scler Relat Disord) - Oct 15, 2026 - "Relapse after switching to OFA is influenced by baseline disability, recent relapse, and prior fingolimod use. Shorter washout may reduce relapse risk in fingolimod switchers. These findings support tailored monitoring and further research to optimise treatment transitions in RRMS."
Journal • CNS Disorders • Multiple Sclerosis
|
|
Allan G Kermode; Anneke van der Walt; Dana Horakova; Emmanuelle Lapointe; Eva Recmanová; Gregor Brecl Jakob; Helmut Butzkueven; Ivana Stetkarova; Izanne Roos; Jana Houskova; Jeannette Lechner-Scott; Jorge Millán-Pascual; José E Meca-Lallana; Julie Prevost; Katrin Gross-Paju; Marek Peterka; Marta Vachova; Marzena Fabis-Pedrini; Matteo Foschi; Michael Zhong; Pamela McCombe; Patrick Reardon; Pavel Stourac; Radek Ampapa; Tomas Kalincik; Vilija Jokubaitis; Zbysek Pavelek
|